Carcinoembryonic antigen surge in metastatic colorectal cancer patients responding to irinotecan combination chemotherapy

被引：11
|
作者：
An, Xin [1 ,2 ]
Ding, Pei-Rong [1 ,3 ]
Xiang, Xiao-Juan [1 ,2 ]
Wang, Zhi-Qiang [1 ,2 ]
Wang, Feng-Hua [1 ,2 ]
Feng, Fen [1 ,2 ]
Jiang, Wen-Qi [1 ,2 ]
He, You-Jian [1 ,2 ]
Xu, Rui-Hua [1 ]
Li, Yu-Hong [1 ,2 ]
机构：
[1] State Key Lab Oncol S China, Guangzhou, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, Guangzhou 510275, Guangdong, Peoples R China
[3] Sun Yat Sen Univ, Ctr Canc, Dept Colorectal Surg, Guangzhou, Guangdong, Peoples R China
来源：
BIOMARKERS | 2010年 / 15卷 / 03期
关键词：
Carcinoembryonic antigen surge; chemotherapy; irinotecan; metastatic colorectal cancer; FOLINIC ACID; COLON-CANCER; TUMOR-MARKER; CEA; EXPRESSION; 5-FLUOROURACIL; OXALIPLATIN; THERAPY; CELLS; INCREASE;
D O I：
10.3109/13547500903477377
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Methods: We retrospectively reviewed 132 patients with metastatic colorectal cancer treated with irinotecan-based chemotherapy. Incidence of a CEA surge and chemotherapy efficacy were investigated. Results: Eleven of 99 eligible patients (11.1%) had CEA surges. None of the 11 patients showed progressive disease (four had a partial response, seven had stable disease). Conclusion: A CEA surge can be induced by irinotecan-based chemotherapy. An early increase in CEA after irinotecan-based chemotherapy does not usually indicate progression of disease and failure of therapy, and should not lead to a change of chemotherapy.
引用
收藏
页码：243 / 248
页数：6
相关论文
共 50 条
  • [1] Carcinoembryonic antigen surge in metastatic colorectal cancer patients responding to oxaliplatin combination chemotherapy: Implications for tumor marker monitoring and guidelines
    Sorbye, H
    Dahl, O
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (23) : 4466 - 4467
  • [2] Chemotherapy-induced carcinoembryonic antigen surge in patients with metastatic colorectal cancer
    Ailawadhi, S
    Sunga, A
    Rajput, A
    Yang, GY
    Smith, J
    Fakih, M
    ONCOLOGY, 2006, 70 (01) : 49 - 53
  • [3] Carcinoembryonic antigen (CEA) surge in patients with metastatic colorectal cancer receiving systemic chemotherapy.
    Sunga, AY
    Ailawadhi, S
    Yang, GY
    Rajput, A
    Smith, JL
    Fakih, MG
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 274S - 274S
  • [4] Carcinoembryonic antigen in monitoring of response to systemic chemotherapy in patients with metastatic colorectal cancer
    Wei-Shu Wang
    Jen-Kou Lin
    Tzu-Chen Lin
    Tzeon-Jye Chiou
    Jin-Hwang Liu
    Frank S. Fan
    Chueh-Chuan Yen
    Wei-Shone Chen
    Jeng-Kae Jiang
    Shung-Haur Yang
    Huann-Sheng Wang
    Po-Min Chen
    International Journal of Colorectal Disease, 2001, 16 : 96 - 101
  • [5] Carcinoembryonic antigen in monitoring of response to systemic chemotherapy in patients with metastatic colorectal cancer
    Wang, WS
    Lin, JK
    Lin, TC
    Chiou, TJ
    Liu, JH
    Fan, FS
    Yen, CC
    Chen, WS
    Jiang, JK
    Yang, SH
    Wang, HS
    Chen, PM
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2001, 16 (02) : 96 - 101
  • [6] Prediction of response to combination chemotherapy with irinotecan in Greek patients with metastatic colorectal cancer
    Isaakidou, Athina
    Gazouli, Maria
    Aravantinos, Gerasimos
    Pectasides, Dimitrios
    Theodoropoulos, George E.
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2016, 12 (01) : 193 - 197
  • [7] Metastatic colorectal cancer:: integrating irinotecan into combination and sequential chemotherapy
    Douillard, JY
    Sobrero, A
    Carnaghi, C
    Comella, P
    Díaz-Rubio, E
    Santoro, A
    Van Cutsem, E
    ANNALS OF ONCOLOGY, 2003, 14 : 7 - 12
  • [8] Carcinoembryonic antigen in metastatic colorectal cancer
    Hamm, CM
    Cripps, C
    CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE, 1998, 21 (4-5): : 186 - 191
  • [9] CAPECITABINE AND IRINOTECAN AS FIRSTLINE CHEMOTHERAPY FOR PATIENTS WITH METASTATIC COLORECTAL CANCER
    Davidov, Deyan
    JOURNAL OF IMAB, 2010, 16 (03): : 74 - 77
  • [10] Carcinoembryonic Antigen Clearance Rate May Be a Prognostic Indicator for Metastatic Colorectal Cancer Patients Receiving Chemotherapy
    Huang, Sheng-Chieh
    Lin, Jen-Kou
    Jiang, Jeng-Kai
    Lin, Tzu-Chen
    Chen, Wei-Shone
    Yang, Shung-Haur
    Wang, Huann-Sheng
    Lin, Chun-Chi
    Chang, Shih-Ching
    INTERNATIONAL SURGERY, 2016, 101 (11-12) : 510 - 516
12345